Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugate
antibody-drug conjugate
ADC Therapeutics gets the nod from the FDA for its CD19-targeted antibody drug conjugate
Biopharma Reporter
Mon, 04/26/21 - 11:55 am
ADC Therapeutics
Zynlonta
antibody-drug conjugate
FDA
relapsed or refractory diffuse large B-cell lymphoma
Macrogenics takes another shot at a novel immune checkpoint
EP Vantage
Fri, 04/23/21 - 11:16 am
Macrogenics
MGC018
antibody-drug conjugate
After Pfizer cancer deal, Pyxis Oncology nabs a hefty $152M series B
Fierce Biotech
Tue, 03/30/21 - 11:49 am
Pyxis
Pfizer
funding
venture capital
antibody-drug conjugate
WCLC: AstraZeneca builds case for growing ADC pipeline with double wins in advanced lung cancer
Endpoints
Fri, 01/29/21 - 10:03 am
AstraZeneca
WCLC
antibody-drug conjugate
datopotomab deruxtecan
Mersana starts to lose its shine
EP Vantage
Wed, 01/6/21 - 10:38 am
Mersana
ovarian cancer
XMT-1536
antibody-drug conjugate
New antibody-drug conjugate partnership has oncology focus
Biopharma Reporter
Wed, 12/16/20 - 10:32 pm
Sterling Pharma Solutions
CDMOs
oncology
cancer
antibody-drug conjugate
Boehringer inks $1.5B NBE buyout, joining Merck in new cancer race
Fierce Biotech
Thu, 12/10/20 - 11:27 am
Boehringer Ingelheim
NBE Therapeutics
M&A
Merck
antibody-drug conjugate
ROR1
Lonza plots 2 manufacturing suites for antibody-drug conjugates at Switzerland site
Fierce Pharma
Wed, 12/2/20 - 11:49 pm
Lonza
drug manufacturing
antibody-drug conjugate
Genmab axes an ADC development program after the data fail to impress
Endpoints
Tue, 11/24/20 - 11:18 pm
Genmab
antibody-drug conjugate
enapotamab vedotin
ADC gets priority review for anti-CD19 blood cancer drug
Fierce Biotech
Fri, 11/20/20 - 11:12 am
FDA
ADC Therapeutics
antibody-drug conjugate
Lonca
relapsed or refractory diffuse large B-cell lymphoma
Attacking pancreatic cancer with a novel immuno-oncology drug conjugate
Fierce Biotech
Mon, 11/9/20 - 09:04 pm
pancreatic cancer
antibody-drug conjugate
oncology
immuno-oncology
Merck inks $2.8B VelosBio buyout to snag anti-ROR1 ADC
Fierce Biotech
Thu, 11/5/20 - 11:12 am
Merck
VelosBio
M&A
antibody-drug conjugate
diffuse large B-cell lymphoma
Exelixis, NBE join forces for discovery and development of ADCs for cancer
Pharmaceutical Business Review
Wed, 09/9/20 - 10:32 am
Exelixis
NBE Therapeutics
antibody-drug conjugate
oncology
Daiichi Sankyo expands DS-1062 study to include patients with triple negative breast cancer
Pharmaceutical Business Review
Thu, 07/2/20 - 11:09 am
Daiichi Sankyo
antibody-drug conjugate
triple negative breast cancer
DS-1062
clinical trials
GSK adds to its trove of positive data for multiple myeloma contender as rivals continue to command the spotlight
Endpoints
Wed, 05/27/20 - 10:54 am
GSK
ASCO 2020
antibody-drug conjugate
belantamab mafodotin
Multiple Myeloma
LegoChem Biosciences, Iksuda collaborate to develop antibody-drug conjugates
Pharmaceutical Business Review
Fri, 04/17/20 - 10:38 am
LegoChem Biosciences
South Korea
oncology
antibody-drug conjugate
Iksuda
Antibody-drug conjugates on the march
Pharmaforum
Thu, 01/30/20 - 10:41 am
antibody-drug conjugate
AstraZeneca
Daiichi Sankyo
Enhertu
Roche cracks China's ADC market open as Kadcyla scores its first breast cancer OK in the country
Endpoints
Thu, 01/23/20 - 12:11 pm
Roche
Kadcyla
China
breast cancer
antibody-drug conjugate
Drug developers take fresh aim at 'guided-missile' cancer drugs
Reuters
Mon, 01/6/20 - 10:38 am
cancer
oncology
drug development
antibody-drug conjugate
Seattle Genetics Claims Arbitration Rights in Daiichi Sankyo ADC Dispute
BioSpace
Tue, 12/3/19 - 10:29 pm
Seattle Genetics
Daiichi Sankyo
antibody-drug conjugate
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »